Athersys
ATHX
#11216
Rank
โ‚ฌ0.72 M
Marketcap
0,01175ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-98.88%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -โ‚ฌ38.74 Million

According to Athersys's latest financial reports the company's current earnings are โ‚ฌ0.08 Million. In 2022 the company made an earning of -โ‚ฌ67.03 Million, an increase over its 2021 earnings that were of -โ‚ฌ75.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ38.74 Million-42.21%
2022 -โ‚ฌ67.03 Million-11.54%
2021 -โ‚ฌ75.77 Million11.14%
2020 -โ‚ฌ68.18 Million72.2%
2019 -โ‚ฌ39.59 Million77.29%
2018 -โ‚ฌ22.33 Million-22.91%
2017 -โ‚ฌ28.97 Million111.89%
2016 -โ‚ฌ13.68 Million-8.52%
2015 -โ‚ฌ14.95 Million-40.81%
2014 -โ‚ฌ25.25 Million18.62%
2013 -โ‚ฌ21.29 Million
2011 -โ‚ฌ12 Million19.71%
2010 -โ‚ฌ10.02 Million-26.28%
2009 -โ‚ฌ13.59 Million-18.21%
2008 -โ‚ฌ16.62 Million-8.28%
2007 -โ‚ฌ18.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.60 B-62,307.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.21 B-25,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.90 B-21,859.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.66 B-18,438.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ11.44 B-31,592.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.35 B-23,080.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
โ‚ฌ0.14 B-499.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚ฌ2.71 Billion 7,351.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚ฌ0.55 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA